International: +1-347-960-6455

Research Reports

Filter By Therapeutic Area

Filtered by Report Category (Indication Pipeline Reports)

Therapy Area
Androgenetic Alopecia Therapeutics – Competitive Landscape, Epidemiology Forecast, and Pipeline Analysis, 2019
Therapeutic Area(s) Dermatology

Androgenetic alopecia is a genetic medical condition, which leads to pattern hair loss in both male and female. A pattern of “M” shaped is commonly seen in patients, followed by thinning of hair over the crown.

Therapy Area
Presbyopia Therapeutics – Pipeline Analysis 2019, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) Ophthalmology

Presbyopia is an ophthalmic disorder, which develops with age, and affects the visual ability to see near objects clearly. Lens behind the iris helps in focusing on near as well as far objects by adjusting its shape. With the progressing age, the lens loses its flexibility, and becomes rigid.

Therapy Area
Constipation Therapeutics – Competitive Landscape, Epidemiology Forecast, and Pipeline Analysis, 2019
Therapeutic Area(s) Gastroenterology

Constipation refers to an irregular bowel movement, which is characterized by lumpy and hard stool, pain in passing the stool, and feeling of incomplete emptying. Additional implications of constipation include hemorrhoids anal fissure, rectal prolapse, and fecal imprecation.

Therapy Area
Hemochromatosis Therapeutics – Competitive Landscape, Epidemiology Forecast, and Pipeline Analysis, 2019
Therapeutic Area(s) Hematology

Hemochromatosis, also known as iron overload, is characterized by iron accumulation in human body. Some of the major symptoms of hemochromatosis/iron overload include weight loss, joint pain, erectile dysfunction in men, and irregular menstrual cycle in women.

Therapy Area
Progressive Supranuclear Palsy (PSP) Therapeutics – Pipeline Analysis 2019, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) Neurology

Progressive supranuclear palsy (PSP), also known as Steele-Richardson-Olszewski syndrome, is a rare brain disorder, which affects behavior and thinking capability of an individual.

Therapy Area
Uveitis Therapeutics - Pipeline Analysis 2019, Clinical Trials and Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) Ophthalmology

Uveitis can be identified as a range of inflammatory conditions causing pain in the middle layer of the eye, uvea. However, it is not limited to uvea, but also affects retina, lens, optic nerve, and vitreous humor. Due to this disorder, eyes appear red and swollen.

Therapy Area
Myelofibrosis (MF) Therapeutics - Pipeline Analysis 2019, Clinical Trials and Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) Oncology

MF is a rare disease identified by the presence of excessive scar tissues in bone marrow that decreases the hematopoietic capacity of the bone marrow. The genetic mutation in the blood stem cells causes MF.

Therapy Area
Myasthenia Gravis (MG) Therapeutics - Pipeline Analysis 2019, Clinical Trials and Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) Musculoskeletal

MG is a neuromuscular disorder, which is characterized by muscle weakness and muscle fatigue. The disease becomes apparent during adulthood, but symptoms may occur at any age.

Therapy Area
Lysosomal Storage Disorder (LSD) Therapeutics - Pipeline Analysis 2019, Clinical Trials and Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) Metabolic

LSD refers to inherited metabolic disorders, which are characterized by enzyme deficiencies. Metachromatic leukodystrophy; Mucolipidosis types I, II/III, and IV; Mucopolysaccharide storage disease; Gaucher disease; Fabry disease; Niemann-Pick disease; Schindler disease types I and II; Tay Sachs disease; Pompe disease; and Sandhoff disease are some of the most common types of LSD.

Therapy Area
Japanese Encephalitis (JE) Therapeutics - Pipeline Analysis 2019, Clinical Trials and Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) Infectious

JE virus is one of the leading causes of vaccine-preventable encephalitis in the Western Pacific and Asia. It is characterized by inflammation in brain. Additional implications of the disease include headache, disorientation, high fever, coma, convulsions, and tremors.

Therapy Area
Hyperhidrosis Therapeutics - Pipeline Analysis 2019, Clinical Trials and Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) Dermatology

Hyperhidrosis is a condition in which a person starts sweating excessively. People suffering from hyperhidrosis experience excessive sweating from their palms, heads, feet, or underarms.

Therapy Area
Hypertrophic Scars Therapeutics - Pipeline Analysis 2019, Clinical Trials and Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) Dermatology

Hypertrophic scar can be identified as a thickened and raised scar that develops at the site where skin is injured. A hypertrophic scar is a result of an abnormal response to a trauma or injury.

Therapy Area
Hyperlipidemia Therapeutics - Pipeline Analysis 2019, Clinical Trials and Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) Metabolic

Rise in level of cholesterol is referred as hyperlipidemia, which can be acquired or genetically inherited. There are two types of hyperlipidemia: hypertriglyceridemia (high blood level of triglycerides), and hypercholesterolemia (high blood cholesterol levels).

Therapy Area
Diabetic Foot Ulcer Therapeutics - Pipeline Analysis 2019, Clinical Trials and Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) Metabolic

Diabetic foot ulcer is a serious condition that occurs due to diabetes. It can be defined as ulceration in foot along with neuropathy or peripheral artery disease of the lower limb in diabetic patients.

Therapy Area
Bronchiectasis Therapeutics - Pipeline Analysis 2019, Clinical Trials and Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) Respiratory

Bronchiectasis affects lungs, and leads to excess accumulation of mucus due to thickening and widening of alveolar walls. Some of the most common symptoms of bronchiectasis are breathlessness, mucus coughing, tiredness, fever, chills, and wheezing sound on breathing.

Therapy Area
Benign Prostatic Hyperplasia Therapeutics - Pipeline Analysis 2019, Clinical Trials and Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) Others

BPH is a non-cancerous medical condition, which is characterized by enlargement of prostate gland. The first phase of BPH starts in puberty, wherein the size of prostate gland becomes double.

Therapy Area
Rhinovirus Infection Therapeutics - Pipeline Analysis 2018, Clinical Trials and Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) InfectiousOthers

Rhinovirus infections, caused by the rhinoviruses, occurs in the upper or lower respiratory tracts. These infections are mostly acknowledged as ‘common cold’; however, they can also lead to pneumonia, sore throats, sinus infections, ear infections, and bronchiolitis.

Therapy Area
Hyperkalemia Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) Others

Hyperkalemia is referred to as increased levels of potassium in blood which results in cardiac arrest and death. Potassium levels above 5.1 mEq/l are considered as the hyperkalemia condition. The main causes of hyperkalemia are potassium sifting out of cells into the blood circulation, adrenal gland diseases, kidney dysfunction, uncontrolled diabetes, breakdown of muscle tissue and red blood cells.

Therapy Area
Achondroplasia Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) Others

Achondroplasia, also termed as ACH and achondroplastic dwarfism, is an autosomal dominant genetic disorder that leads to short-stature/ limb dwarfism. It is caused due to abnormal cartilage formation. Cartilage is responsible for the development of skeleton and initial bone growth.

Therapy Area
Wiskott-Aldrich Syndrome Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) Others

Wiskott-Aldrich syndrome is a hereditary immunodeficiency disorder characterized by abnormal functioning of immune system and decreased ability to form blood clots. The abnormality in the platelets leads to easy bruising effects in case of prolonged bleeding.

Therapy Area
Vaginitis Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) Others

Vaginitis refers to the inflammation of vagina. It affects women of all ages but is most common during the reproductive years. Vaginitis occurs due to change in the balance of the yeast and bacteria that normally live in the vagina.

Therapy Area
Uterine Fibroids Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) Others

Uterine fibroids, also known as leiomyomas or myomas, are non-cancerous growths that develop from the muscle tissue of the uterus. The size, shape, and location of fibroids can vary greatly.

Therapy Area
Turner Syndrome Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) Others

Turner syndrome is a chromosomal condition, which occurs when one of the two X chromosomes normally found in women is missing or incomplete. The disease alters the growth and development in females.

Therapy Area
Reperfusion Injury Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) Others

Reperfusion injury is the damage to tissues caused when blood supply returns to the tissue after a period of ischemia or lack of oxygen (anoxia, hypoxia). It influences the patient’s outcome after myocardial infarction, stroke, cardiovascular surgery, and organ transplantation.

Therapy Area
Post-Operative Nausea and Vomiting Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) Others

Post-operative nausea and vomiting is one of the complications of anaesthesia given to the patients at the time of a surgery. The state of having unpleasant sensation subjected to desire of vomiting is known as nausea whereas, vomiting is the forceful expulsion contents present in gastrointestinal tracts.

Therapy Area
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) Others

Mucopolysaccharidosis type III (MPS III), also known as Sanfilippo syndrome, is a progressive disorder that primarily affects brain and spinal cord (central nervous system). People with MPS III generally do not display features at birth, but they begin to show signs and symptoms of this disorder during early childhood.

Therapy Area
Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) Others

Mucopolysaccharidosis type II (MPS II), also known as Hunter syndrome, is a condition that affects various parts of the body and occurs almost exclusively in males. It is a progressively debilitating disorder; however, the rate of progression varies among affected individuals.

Therapy Area
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) Others

Mucopolysaccharidosis type I (MPS I) is a condition that affects many parts of the body. Earlier, MPS I disorder was divided into three separate syndromes; Hurler syndrome (MPS I-H), Hurler-Scheie syndrome (MPS I-H/S), and Scheie syndrome (MPS I-S), listed from most to least severe. Later on, these were clubbed as one disease, due to overlap between each of these three syndromes.

Therapy Area
Ischemia Reperfusion Injury Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) Others

Ischemia reperfusion injury is a medical condition which involves tissue injury, resulting in the interruption of blood supply, and occurs when the blood supply to an area of tissue is cut off. Ischemia-related tissue injury can occur in various organs including heart and brain. During reperfusion injury, inflammatory responses occur including release of free radicals, vascular leakage, recruitment of inflammatory cells, and proteins that cause tissue destruction.

Therapy Area
Infertility Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) Others

Infertility is defined as the biological inability to conceive or contribute to conception, after having regular unprotected sex. According to the data published by the Department of Health and Human Services, approximately 10% to 15% of couples in the U.S. are infertile and have not conceived after at least one year of regular, unprotected sex

Therapy Area
Hypoxic-Ischemic Encephalopathy Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) Others

Hypoxic-ischemic encephalopathy is a serious birth complication that causes obstruction in blood flow in brain during the prenatal, intrapartum or postnatal period. This leads to death of the child or mental disabilities in the first two years of age.

Therapy Area
Hypoxia Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) Others

Hypoxia is a condition characterized by inability of the tissues to receive an adequate oxygen supply. This condition is categorized into four types; hypoxic, stagnant, anaemic, fulminating, and histotoxic hypoxia.

Therapy Area
Hypoxia-Inducible Factor (HIF) Inhibitor Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) Others

Hypoxia-inducible factor (HIF) inhibitor inhibits the HIF mediated hypoxic responses. HIF is a transcription factor that activate when there is a decrease in the availability of oxygen in the cellular environment. Hypoxia promotes the formation of blood vessels and this homeostatic system is required in formation of vascular system in the embryo.

Therapy Area
Hyperphosphatemia Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) Others

Hyperphosphatemia is a medical condition which involves increased level of serum phosphate concentration in the blood. Phosphate is required for bone and cell formation, genetic coding and energy metabolism. An individual is said to have hyperphosphatemia, if the phosphate concentration increasing beyond > 4.5 mg/dL (> 1.46 mmol/L).

Therapy Area
Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) Others

Prostate cancer occurs when cells in prostate glands grow uncontrollably. Prostate is an exocrine gland that makes the fluid part of semen and lie below the bladder in front of the rectum. As per the National Institute of Health (NIH), 10.7% of all new cases of cancer in the U.S. are of prostate cancer.

Therapy Area
Hormonal Replacement Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) Others

Hormonal replacement therapy is a type of treatment wherein patients receive a course of hormones in order to get relieve from the menopause related problems. The therapy involves administration of synthetic estrogen and progesterone to overcome decreasing hormone level of women. 

Therapy Area
Heterozygous Familial Hypercholesterolemia (heFH) Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) Others

Heterozygous familial hypercholesterolemia (HeFH) is an inherited genetic disorder that affects the body’s ability to control cholesterol. It is characterized by very high LDL (low density lipoprotein) cholesterol (above 190 for adults or above 160 for children) and family history of high cholesterol, heart disease or stroke.

Therapy Area
Hematopoietic Stem Cell (HSC) Mobilization Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) Others

Mobilization is the recruitment of hematopoietic stem cells (HSC) into peripheral blood from the bone marrow following chemotherapy treatment. There are several advantages for reinfusion of autologous mobilized peripheral blood stem cells over bone marrow HSC.

Therapy Area
Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) Others

Globoid cell leukodystrophy, also known as Krabbe disease, is a genetic disorder which is characterized by decreased production of galactocerebrosidase. The symptoms observed during Krabbe disease are fever, vomiting, loss of head control, irritability and excessive crying, seizures, poor coordination of movement or stiffness, muscle spasms, changes in muscle tone, deterioration of motor function, difficulty walking and muscle weakness.

Therapy Area
Female Sexual Dysfunction (FSD) Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) Others

Female sexual dysfunction (FSD) prevents the females to experience satisfaction from the sexual activity. FSD can be developed during any phase of the sexual response cycle which consists of excitement, plateau, orgasm and resolution phases.

Therapy Area
Female Contraception Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) Others

Female contraception prevents unwanted or unintended pregnancy. When the matured egg cell leave the ovary and ovulation begins, the chances of becoming pregnant increases. The main advantage of using contraceptives is reduction in menstrual bleeding and period pain.

Therapy Area
Epidermolysis Bullosa (EB) Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) Others

Epidermolysis bullosa (EB), is a rare genetic connective tissue skin disorder that causes blisters and allows skin to become fragile. Blisters and areas of skin loss (erosions) occur in response to minor injury or friction, such as rubbing or scratching.

Therapy Area
Dental Pain Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) Others

Dental pain, also known as odontogenic pain or tooth pain, arises from the teeth or their supporting structures which includes mucosa, gingivae, maxilla, mandible, or periodontal membrane. The primary location of the reflected pain (orofacial pain) is the spinal core of trigeminal system.

Therapy Area
Viral Bronchiolitis Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) RespiratoryOthers

Viral bronchiolitis is an inflammatory disorder which is characterized by obstruction of small airways, necrosis and edema of the epithelial cells, and increased mucus production. The disease is most commonly caused by an infection caused by respiratory syncytial virus.

Therapy Area
Pleural Effusion Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) RespiratoryOthers

Pleural effusion is the fluid build-up in the pleural space and is categorized into two types which includes exudate and transudate. Transudate is usually composed of ultra-filtrates of plasma due to heart failure or cirrhosis; while, exudate is caused by inflammatory conditions.

Therapy Area
Interstitial Lung Disease Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) RespiratoryOthers

Interstitial lung disease is a type of inflammatory disease that affects and thickens the interstitium of the lungs. The interstitium is a lace like network of the tissue that provide support to the air sacs and the capillaries in the interstitium which allows the gas exchange between the blood and alveolar tissues.

Therapy Area
Urea Cycle Disorders (UCDs) Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) UrologyOthers

Urea cycle disorders (UCDs) are an inborn error of metabolism, that occurs due to the deficiencies in any of the six enzymes and two transport proteins involved in urea biosynthesis. These disorders cause inborn errors in urea synthesis that lead to an accumulation of ammonia in blood and brain.

Therapy Area
Hyperoxaluria Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) UrologyOthers

Hyperoxaluria is a medical condition which involves increased oxalate in urine. The causes of hyperoxaluria include consumption of oxalate-rich foods, intestinal disorders and genetic disorders. The disease is categorized into different types which includes primary hyperoxaluria, enteric hyperoxaluria and hyperoxaluria related to eating high-oxalate foods.

Therapy Area
Graves’ Ophthalmopathy Therapeutics - Pipeline Analysis 2019, Clinical Trials and Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) OphthalmologyOthers

Graves’ ophthalmopathy (also called Graves’ orbitopathy; thyroid eye disease (TED); dysthyroid/thyroid-associated orbitopathy (TAO)) is an autoimmune disorder wherein ocular and orbital tissues are affected by the overproduction of thyroid hormones.

Therapy Area
Choroidal Neovascularization Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) OphthalmologyOthers

Choroidal neovascularization is a type of medical condition in which new blood vessels are formed from choroid and extend into the subretinal space, or subretinal pigment epithelium, or a combination of both. The disease can be symptomatized by a painless loss of vision, paracentral or central scotoma, and metamorphopsia. 

Therapy Area
Uveal Melanoma Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) OncologyOthers

Uveal melanoma is the most common primary malignant tumour of intraocular malignancy, arises from melanocytes in the iris, and ciliary body. The most common symptoms of uveal carcinoma include blurred vision, photopsia, visual field loss, visible tumour, pain, and metamorphopsia.

Therapy Area
Tuberous Sclerosis Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) OncologyOthers

Tuberous sclerosis, also known as tuberous sclerosis complex, is a genetic disorder characterized by the growth of numerous noncancerous (benign) tumors in many parts of the body. It can occur in the brain, skin, kidneys, and other organs, in some cases leading to significant health problems.

Therapy Area
Thymic Carcinoma Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) OncologyOthers

Thymic carcinoma, also known as thymomas, is a rare type of cancer that forms in the cells present in the outside surface of the thymus. Thymus is a small organ that lies in the upper chest under the breastbone.

Therapy Area
Sezary Syndrome Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) OncologyOthers

Sézary syndrome, a type of cutaneous T-cell lymphoma, affects Sézary cells present in the skin, lymph nodes and blood. It accounts approximately 3 to 5 percent of cases of cutaneous T-cell lymphoma. Sézary syndrome is more prevalent in males compared to females.

Therapy Area
Pontine Glioma Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) OncologyOthers

Pontine glioma is a malignant tumour which develops from the brain stem cells. Based on the grade of growth, it is categorized into anaplastic astrocytomas and glioblastoma multiforme (GBM). Pontine glioma is more prevalent in children than adults.

Therapy Area
Juvenile Myelomonocytic Leukemia Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) OncologyOthers

Juvenile myelomonocytic leukemia is a rare disease that occurs mostly in the children who are under four years of age. The abnormal growth of the monocytes results in the accumulation of monocytes in the bone marrow.

Therapy Area
Hypopharyngeal Cancer Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) OncologyOthers

Hypopharyngeal cancer, a type of head and neck cancer, develops in hypopharynx. Pharynx is a hollow tube about five inches long, and the bottom part of the pharynx called hypopharynx. Most of the hypopharyngeal malignancy occurs in squamous cells.

Therapy Area
Hormone Sensitive Breast Cancer Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) OncologyOthers

Breast cancer generally occurs when breast cells grow uncontrollably. Mostly, breast cancer development starts in the duct that carries milk to the nipples. Some breast cancer cells develop in milk producing glands. As per the National Institutes of Health (NIH), in the U.S., 14.6% of all new cancer cases diagnosed every year are of breast cancer.

Therapy Area
Gorlin Syndrome Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) OncologyOthers

Gorlin syndrome, also known as basal cell nevus syndrome, is an inherited genetic disorder characterized by multiple basal cell skin cancer. The common symptoms observed during Gorlin syndrome are calcium deposition in brain, jaw cysts, skeletal changes and developmental disability.

Therapy Area
Bone Metastases Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) OncologyOthers

Bone metastases is a common form of cancer of the skeleton that inhabits in bone marrow and stimulates the local bone activity. In this condition, the normal bone homeostasis disrupts which leads to the development of the tumour. Some of the major symptoms observed in patients with bone metastases are bone pain, spinal cord compression, and high blood calcium levels.

Therapy Area
Angioimmunoblastic T-Cell Lymphoma (AITL) Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) OncologyOthers

Angioimmunoblastic T-cell lymphoma is a rare type of peripheral T-cell lymphoma which is characterized by lymphadenopathy, fever, and arthritis. The signs and symptoms associated with the disease include pleural effusion, arthritis, edema, ascites and pruritic skin rash.

Therapy Area
Acquired Immunodeficiency Syndrome (AIDS) Related Cancer Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) OncologyOthers

Acquired immunodeficiency syndrome (AIDS) related cancer include those types of cancer which occurs in patients suffering from AIDS. People with AIDS are reported to be highly suspected to the occurrence of lymphomas.

Therapy Area
Adrenocortical Carcinoma Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) OncologyOthers

Adrenocortical carcinoma, also known as adrenal cortex carcinoma, is a rare form of cancer that occurs at the cortex layer of the adrenal gland. There are two adrenal glands present in the human body: one at the top of each kidney.

Therapy Area
Visceral Pain Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) NeurologyOthers

Visceral pain is the most frequent form of clinically relevant pain for those patients seek medical attention. There are several causes of visceral pain. Nociceptive pain causes direct injury of an internal organs, that leads to cardiac ischemic, and peptic ulcer. Medications for visceral pain treatment includes analgesics such as nonsteroidal anti-inflammatory drugs, paracetamol and serotonergic compounds.

Therapy Area
Tay-Sachs Disease Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) NeurologyOthers

Tay-Sachs is a lysosomal storage disorder caused by the deficiency of vital enzymes called beta-hexosaminidase A (Hex-A). The role of Hex-A is to degrade a fatty substance or lipid called GM-2 ganglioside.

Therapy Area
Tardive Dyskinesia Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) NeurologyOthers

Tardive dyskinesia (TD) is an involuntary neurological movement disorder caused by the use of dopamine receptor blocking drugs which are prescribed to treat certain psychiatric or gastrointestinal conditions. Long-term use of these drugs may produce biochemical abnormalities in the area of the brain known as the striatum.

Therapy Area
Major Depressive Disorder Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) NeurologyOthers

Major depressive disorder, also known as the clinical depression, is characterized by a constant sense of despair and hopelessness. It usually affects daily activities such as study, sleep, and eating.

Therapy Area
Lewy Body Dementia Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) NephrologyOthers

Lewy body dementia is a progressive brain disorder in which Lewy bodies build up in different parts of the brain that regulate cognition, movement and behavior. Lewy bodies are abnormal deposition of a protein called alpha-synuclein.

Therapy Area
Ischemic Stroke Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) NeurologyOthers

Ischemic stroke develops due to an obstruction within a blood vessel which supply blood to the brain. The underlying condition for this type of obstruction is atherosclerosis, which is characterized by fatty deposition or plaque build-up in the blood vessels.

Therapy Area
Infantile Spasm Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) NeurologyOthers

Infantile spasm, also known as West syndrome, is a rare type of seizure disorder which is characterized by sudden stiffening of the body, legs and arms, and forward bending of head. It is diagnosed by physical examination, neurological examination, electroencephalography (EEG), magnetic resonance imaging (MRI), blood tests and urine tests.

Therapy Area
Hypersomnia Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) NeurologyOthers

Hypersomnia is a medical condition which is characterized by excessive daytime sleepiness. It is categorized into primary hypersomnia and secondary hypersomnia. People with hypersomnia also suffer from other sleep-related problems, such as clear thinking problems and lack of energy. 

Therapy Area
Hyperalgesia Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) NeurologyOthers

Hyperalgesia is a medical condition in which a person develops an increased sensitivity towards pain. There are several nerve pathways in the body where signals can start miscommunication with each other, resulting in hyperalgesia.

Therapy Area
Essential Tremor Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) NeurologyOthers

Essential tremor, a nerve disorder, is characterized by involuntary tremors or shaking in different parts of the body. The most common affected areas are head, arms, hands, larynx, chin and tongue. This disease creates difficulties in daily activities such as eating, writing and dressing.

Therapy Area
Dravet Syndrome Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) NeurologyOthers

Dravet syndrome is a form of severe myoclonic epilepsy that occurs in infants during their first year of age. If left untreated, it can be associated with other types of seizures, and status epilepticus. Children having Dravet syndrome are generally observed with poor cognitive skills and hyperactivity.

Therapy Area
Dementia Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) NeurologyOthers

Dementia is a group of neurological disorders which is characterized by impaired intellectual functioning. People having dementia generally lose the ability to maintain emotional control and solve the problems.

Therapy Area
Complex Regional Pain Syndrome (CRPS) Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) NeurologyOthers

Complex regional pain syndrome (CRPS) is a type of chronic pain that affects one limb of the body (hand, leg, arm, or foot). The condition generally arises due to severe injuries or malfunctioning of central and peripheral nervous systems. CRPS is categorized into two main types: CRPS-I and CRPS-II.

Therapy Area
Cognitive Impairment Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) NeurologyOthers

Cognitive impairment is a medical condition in which people lose their cognitive capabilities such as thinking skills and memory. People having cognitive impairment are at high risk of developing dementia or Alzheimer’s disease. Cognitive impairment that affects memory is known as amnestic mild cognitive impairment (MCI); and the condition which affects thinking skills called nonamnestic MCI.

Therapy Area
Chronic and Low Back Pain Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) NeurologyOthers

Chronic and low back pain is a constant and dull ache and creates a sharp sensation that leaves a person harmed. It can occur due to sciatica, spondylolisthesis, spinal stenosis, traumatic injury, herniated or ruptured discs, and intervertebral disc degeneration.

Therapy Area
Cerebral Palsy Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) NeurologyOthers

In cerebral palsy, the term cerebral refers to brain and palsy refers to the loss or impairment of motor function. Cerebral palsy is a group of neurological disorders that appear in infancy or early childhood, and permanently affect body movement and muscle coordination.

Therapy Area
Asperger Syndrome Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) NeurologyOthers

Asperger syndrome is an autism spectrum disorder characterized by impaired communication skills and repetitive thoughts or behavior. Symptoms associated with the Asperger syndrome are lack of speech recognition skills, dislike for routine changes, avoidance of eye contacts, unusual facial expressions, and delayed motor development. 

Therapy Area
Von Hippel-Lindau Syndrome Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) NephrologyOthers

Von Hippel-Lindau syndrome is a genetic disorder characterized by formation of cysts and tumors in different parts of the body. The symptoms associated with the disease depends upon the location of tumor.

Therapy Area
Focal Segmental Glomerulosclerosis (FSGS) Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) NephrologyOthers

Focal segmental glomerulosclerosis (FSGS) is a glomerular disease, which is characterized by scarring or sclerosis in the kidney. Scarring damages the limited number of glomeruli in the initial stages. It is more common in males than in females, and is very common in African American population.

Therapy Area
Tic Disorder Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) MusculoskeletalOthers

Tic disorder is a type of mental disorder, characterized by sudden and nonrhythmic movements. According to the World Health Organisation (WHO), this disease can be categorized into five types; transient, combined vocal and multiple motor, unspecified, and chronic motor tic disorder.

Therapy Area
Spasticity Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) MusculoskeletalOthers

Spasticity is a condition in which certain muscles are continuously contracted. The constant muscle contraction causes stiffness or tightness of the muscles and can interfere with normal movement, speech and gait in a patient.

Therapy Area
Polymyalgia Rheumatica Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) MusculoskeletalOthers

Polymyalgia rheumatica is an inflammatory disorder which causes stiffness and aching, and usually affects adults over the age of 50 years. This disease affects women somewhat more than men. The cause of polymyalgia rheumatica is unknown.

Therapy Area
Musculoskeletal Pain Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) MusculoskeletalOthers

Musculoskeletal pain is a known consequence of repetitive strain, overuse, and work-related musculoskeletal disorders. These injuries include a variety of disorders that cause pain in muscles, bones, joints, or surrounding structures.

Therapy Area
Intermittent Claudication Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) MusculoskeletalOthers

Intermittent claudication refers to aching or squeezing pain in thighs, buttocks or feet during exercise, due to insufficient blood circulation resulting from peripheral arterial disease. The probability of developing peripheral arterial disease increases with the age.

Therapy Area
Fibrodysplasia Ossificans Progressiva (FOP) Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) MusculoskeletalOthers

Fibrodysplasia ossificans progressiva (FOP), also known as myositis ossificans progressive, is a rare inherited connective tissue disorder characterized by abnormal bone development in ligaments, tendons, and skeletal muscles. Precisely, FOP causes the body's skeletal muscles and soft connective tissues to undergo a metamorphosis, transforming into bone, gradually locking joints and making movement difficult.

Therapy Area
Fatigue Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) MusculoskeletalOthers

Fatigue is referred to as lack of energy and feeling of tiredness, both physically and mentally. There are several causes for fatigue, and it is also a common side effect of certain medicines. Symptoms associated with the fatigue are weight loss, fever, anxiety, depression, muscle weakness, vomiting, diarrhoea, and chest pain.

Therapy Area
Dystonia Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) MusculoskeletalOthers

Dystonia is a type of movement disorder in which sustained muscle contraction occurs. The twisting and repetitive movements are the prominent characteristics observed in patients with this disease. Some of the early symptoms of the disease are dragging foot after running, deterioration in handwriting, foot cramps, tremor, and speech difficulties.

Therapy Area
Dyskinesia Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) MusculoskeletalOthers

Dyskinesia is a type of movement disorder, characterized by irregular and involuntary muscle movements, and diminished voluntary movements. This disease can occur in patients taking antipsychotic medication or having severe mental disorders, such as Parkinson’s and Huntington’s disease. Levodopa-induced dyskinesia is observed in patients with Parkinson’s disease.

Therapy Area
Degenerative Intervertebral-Disc Disease Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) MusculoskeletalOthers

Degenerative intervertebral-disc disease is characterized by degeneration of one or more disc in the vertebrae. The function of the intervertebral disc is to provide the cushioning between vertebrae. It has been observed that intervertebral discs of the lumbar region are mostly affected.

Therapy Area
Blepharospasm Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) MusculoskeletalOthers

Blepharospasm is an abnormal involuntary twitching of eyelid. The actual cause of the disease is still unknown but it has been observed that the disease occurs due to abnormal functioning of basal ganglion, which is responsible for the movement of muscles.

Therapy Area
Ataxia Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) MusculoskeletalOthers

Ataxia is a type of movement disorder characterized by lack of muscle control or coordination of voluntary movements. Some of the symptoms observed in the patients with ataxia are poor coordination, change in speech, difficulty in swallowing, and unsteady walk.

Therapy Area
Lipodystrophy Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) MetabolicOthers

Lipodystrophy is a rare medical condition which involves problems with fat production, usage, and storage. It is categorized into two types; congenital and acquired lipodystrophy.

Therapy Area
Growth Hormone Deficiency Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) MetabolicOthers

Growth hormone deficiency is a congenital or acquired hormonal disorder, that is characterized by short stature due to lack of growth hormone. 

Therapy Area
Trypanosomiasis Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) InfectiousOthers

Trypanosomiasis is an infectious disease caused by the parasite of the genus Trypanosoma. African trypanosomiasis, or sleeping sickness, is caused by Trypanosoma brucei parasites in sub-Saharan Africa and American trypanosomiasis, or Chagas disease, is caused by Trypanosoma cruzi parasites in Latin America and is transmitted by the triatomine or ‘kissing’ bug. 

Therapy Area
Tetanus Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) InfectiousOthers

Tetanus, also known as lockjaw is a bacterial disease caused by Clostridium tetani. The bacteria are usually found in dust, soil, and manure and enter the body through breaks in the skin. The spores develop into bacteria when they enter the body. 

Therapy Area
Streptococcal Infections Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) InfectiousOthers

Streptococcal infections are caused by any one of several species of Streptococcus. These infections can spread through coughing or sneezing, contact with infected wounds or sores, or during a vaginal delivery.

Therapy Area
Shigella Infection (Shigellosis) Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) InfectiousOthers

Shigella infection, also known as shigellosis, is a bacterial infection caused by a family of bacteria known as shigella. The main symptom of this infection is diarrhea, and can be passed through direct contact with the bacteria in the stool.

Therapy Area
Sepsis Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) InfectiousOthers

Sepsis refers to inflammation throughout the body, as a result of immune response to fight an infection. Severe cases of sepsis can lead to septic shock. 

Therapy Area
Schistosomiasis Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) InfectiousOthers

Schistosomiasis is an acute and chronic disease caused by parasitic worms of the genus Schistosoma, during routine domestic, occupational, agricultural, and recreational activities, which involves infested water exposure. 

Therapy Area
Plague Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) InfectiousOthers

Plague is an enzootic vector borne disease and a type of infectious disease, that is caused by the bacterium Yersinia pestis. This bacterium is generally found in the flea that affects human and other mammals.

Therapy Area
Mycoses Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) InfectiousOthers

Mycoses, also known as fungal infections are categorized into different types based on their invasiveness. The different types of mycoses are superficial, cutaneous, subcutaneous, dimorphic systemic, and opportunistic systemic mycoses.

Therapy Area
Mumps Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) InfectiousOthers

Mumps is a transmissible disease caused by the mumps virus and is characterized by swelling of glands in neck and face. Some of the symptoms of this disease are headache, fever, tiredness, loss of appetite, and muscle ache. 

Therapy Area
Middle East Respiratory Syndrome (MERS) Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) InfectiousOthers

Middle East respiratory syndrome (MERS) is a viral respiratory disease caused by a coronavirus (MERS-CoV). Coronaviruses are a type of viruses that affect the respiratory tract of mammals, including humans. Human coronaviruses usually cause mild to moderate cold-like illnesses.

Therapy Area
Klebsiella Infections Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) InfectiousOthers

Klebsiella infections include different types of infections like bloodstream infections; pneumonia; wound or surgical site infections; and meningitis, caused by the Klebsiella bacteria.

Therapy Area
Impetigo Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) InfectiousOthers

Impetigo is a common bacterial infection caused by different kinds of bacteria, including streptococcus and staphylococcus. It is a contagious disease and begins with appearance of red sores on any part of the body, which eventually changes to blisters on the body.

Therapy Area
Hospital Acquired Pneumonia (HAP) Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) InfectiousOthers

Hospital acquired pneumonia (HAP) is a lung infection that occurs during hospital stay. HAP can spread via health care workers, who may pass germs from their hands or clothes from one patient to another. This is why hand-washing, wearing gowns, and using other safety measures is so important in hospitals and other healthcare settings.

Therapy Area
Herpes Labialis Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) InfectiousOthers

Herpes labialis, also known as oral herpes, is a mouth infection which leads to the development of small, painful blisters on gums, throat, and lips. The blisters are caused by herpes simplex virus, which is highly contagious and is known to infect a larger portion of population in the U.S.

Therapy Area
Haemophilus Infections Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) InfectiousOthers

Haemophilus infections are the bacterial infections including septic arthritis, meningitis, pneumonia, otitis media, sinusitis, conjunctivitis, tracheobronchitis, and acute epiglottitis caused by the Haemophilus sp. 

Therapy Area
Gram-Positive Bacterial Infections Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) InfectiousOthers

Gram-positive bacterial infections are caused by gram-positive bacteria, such as Staphylococcus aureus and Enterococcus spp. This infection sometimes become fatal in the immune-compromised person, and it is generally found in new-born.

Therapy Area
Diphtheria Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) InfectiousOthers

Diphtheria is an infectious and vaccine preventable disease caused by Corynebacterium diphtheriae. It is generally characterized by upper respiratory tract infection, and the most common sites for this disease are pharynx and tonsils. 

Therapy Area
Cryptosporidiosis Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) InfectiousOthers

Cryptosporidiosis is a severe form of illness caused by parasites of various Cryptosporidium species. A person can be infected by parasites by having contaminated food and water or coming in contact with contaminated places. 

Therapy Area
Community Acquired Pneumonia Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) InfectiousOthers

Community acquired pneumonia is a type of pneumonia acquired in extended care facilities. This condition can cause decreased lung function, fever, chest pain, dyspnea, and cough.

Therapy Area
Chagas Disease (American Trypanosomiasis) Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) InfectiousOthers

Chagas disease, also known as American trypanosomiasis, is a potentially life-threatening condition caused by the protozoan parasite Trypanosoma cruzi (T. cruzi). Chagas disease occurs principally in the continental part of Latin America, and not in the Caribbean isles. 

Therapy Area
Blepharitis Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) InfectiousOthers

Blepharitis is an inflammatory disorder of eyelids and can be categorized into two types; anterior and posterior blepharitis. The inflammation at the outside front of the eyelid is anterior blepharitis, whereas, inflammation at the inner eyelid is posterior blepharitis.

Therapy Area
Bacterial Endocarditis Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) InfectiousOthers

Bacterial endocarditis is an infection of inner lining of the valves and heart chamber. This infection can cause serious inflammation in heart and can develop fatal complications

Therapy Area
Wegener’s Granulomatosis Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) ImmunologyOthers

Wegener’s granulomatosis, also known as granulomatosis with polyangiitis, is a type of an inflammatory and autoimmune disorder that limits the blood flow to organs, leading to organ damage. 

Therapy Area
Sarcoidosis Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) ImmunologyOthers

Sarcoidosis is an inflammatory disorder that affects many organs in the body, such as lymph glands and lungs. Abnormal nodules are formed in the affected organs, impacting the structure and function of the organ during sarcoidosis. 

Therapy Area
Primary Immune Deficiency Diseases Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) ImmunologyOthers

Primary immune deficiency diseases are rare and genetic disorders, that are characterized by an impaired immune system. Some of the symptoms observed in the patients with these diseases are blood disorders, autoimmune disorders, recurrent pneumonia, inflammation of internal organs, and digestive problems. 

Therapy Area
Kidney Transplant Rejection Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) ImmunologyOthers

Kidney transplant rejection occurs due to an immune response toward the foreign antigens from the donor kidney. It is categorized into three different types; hyper-acute, acute, and chronic kidney transplant rejection. 

Therapy Area
Hypersensitivity Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) ImmunologyOthers

Hypersensitivity is a group of undesirable reactions that are produced by normal immune systems, due to allergies and autoimmune disorders in body. These are considered as an over-reaction by the immune system and can be damaging, uncomfortable, or occasionally incurable. 

Therapy Area
Heart Transplant Rejection Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) ImmunologyOthers

Heart transplantation is the most feasible surgical transplant for the patients with end-stage heart disease. In a heart transplant surgery damaged or diseased heart is replaced with a healthy one. Transplant rejection is very common due to T cell response toward the graft or new heart. 

Therapy Area
Guillain-Barre Syndrome Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) ImmunologyOthers

Guillain-barre syndrome (GBS) is an immunological disorder in which the body’s immune system acts against the peripheral nervous system. In this condition, the body’s immunity starts to destroy the myelin sheath that surrounds the axons of peripheral nerves. 

Therapy Area
Autoimmune Hepatitis Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) ImmunologyOthers

Autoimmune hepatitis is a chronic inflammatory disorder, characterized by autoantibodies, elevated immunoglobulin, and peritoneal inflammation. According to researchers, environmental triggers, genetic predisposition, and autoimmunity are some causes for the occurrence of this disease.

Therapy Area
Allergy Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) ImmunologyOthers

Allergy is an immune system response, that can range from mild to severe life-threatening reactions. The substances that can cause an allergy are known as allergens. Some common allergens include pollen, dust, insect stings, medications, mold spores, latex, and animal dander.

Therapy Area
Septicaemia Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) HematologyOthers

Septicemia, also known as bacteremia or blood poisoning, is characterized by bacterial blood infection. Septicemia occurs as a result of bacterial infection elsewhere in the body, which enters in the bloodstream. 

Therapy Area
Porphyria Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) HematologyOthers

Porphyria is a group of disorders including cutaneous porphyria and acute porphyria. Cutaneous porphyria affects the skin while acute porphyria affects the nervous system. Porphyria cutanea tarda is the most common type of porphyria prevalent in the U.S.

Therapy Area
Iron Deficiency Anemia Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) HematologyOthers

Iron deficiency anemia is a common type of anemia, which is a result of decreased level of haemoglobin in red blood cells (RBCs). There are several causes for iron deficiency anemia, such as inadequate iron intake, pregnancy or blood loss due to menstruation, internal bleeding, and body’s inability to absorb iron.

Therapy Area
Hypereosinophilic Syndrome Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) HematologyOthers

Hypereosinophilic syndrome is a group of rare blood disorders which is characterized by increased number of eosinophils. These eosinophils make their way into various tissues, causing inflammation and eventually organ dysfunction. The most commonly involved organs in hypereosinophilic syndrome include heart, lung, skin and nervous system.

Therapy Area
Hemorrhagic Shock Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) HematologyOthers

Hemorrhagic shock, also known as hypovolemic shock, is characterized by loss of more than 20% of the blood or body fluids. This leads to improper blood supply to the body which results in the organ failure. Some of the major causes of hypovolemic shock are internal bleeding, vaginal bleeding, bleeding from accidental injuries, severe burns, excessive sweating and vomiting, and excessive diarrhea.

Therapy Area
Hemophagocytic Lymphohistiocytosis (HLH) Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) HematologyOthers

Hemophagocytic lymphohistiocytosis (HLH) is a medical condition in which the human body develops large number of activated immune cells, known as macrophages and lymphocytes. Person suffering from HLH usually develop symptoms within the first month or year of life.

Therapy Area
Fanconi’s Anemia Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) HematologyOthers

Fanconi anemia is an inherited disease, caused by mutations in FA genes. These genes provide instructions to repair certain types of DNA damage in the human body. The cells of healthy people often repair DNA damage; however, cells affected by Fanconi anemia are not able to repair damages. 

Therapy Area
Fibrinogen Deficiency Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) HematologyOthers

Fibrinogen deficiency, also known as factor I deficiency, is an inherited bleeding disorder which prevent blood clot formation in the human body. Hypofibrinogenemia, afibrinogenemia, dysfibrinogenemia and hypodysfibrinogenemia are most commonly occurring fibrinogen deficiency disorders. The symptoms of this deficiency vary based on the type of disorder.

Therapy Area
Atypical Hemolytic Uremic Syndrome (aHUS) Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) HematologyOthers

Atypical hemolytic uremic syndrome (aHUS), also known as non-diarrhea - associated hemolytic uremic syndrome, is a rare disease characterized by hemolytic anemia, thrombocytopenia, acute kidney failure and uremia. The signs and symptoms of aHUS include formation of tiny blood clots in various small blood vessels of the body.

Therapy Area
Proctitis Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) GastroenterologyOthers

Proctitis is characterized by the inflamed lining tissue of the inner rectum due to several medical conditions. The common causes of proctitis are sexually-transmitted infections (STIs), inflammatory bowel diseases (ulcerative colitis and Crohn’s disease), anal trauma, rectal infections, and radiation therapy for ovarian, anal, rectal, or prostate cancer.

Therapy Area
Pouchitis Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) GastroenterologyOthers

Pouchitis is an inflammatory disorder that develops when the ileal pouch becomes inflamed and irritated. Increased bowel frequency, bloody stool, incontinence, straining during defecation, tenesmus, lower abdominal pain and abdominal cramping or bloating are some of the problems observed in pouchitis.

Therapy Area
Postoperative Ileus Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) GastroenterologyOthers

Postoperative ileus is defined as malfunctioning of intestinal motility after major abdominal surgeries. It generally affects large number of patients who are undergoing bowel resection surgery which causes significant discomfort and extend hospital stay. Postoperative ileus affects small intestine, stomach and large intestine. The disease is broadly categorized into primary and secondary type.

Therapy Area
Opioid-Induced Bowel Dysfunction Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) GastroenterologyOthers

Opioid-induced bowel dysfunction occurs due to excessive consumption of opioids to manage pain. Opioid is generally use in the clinical management of pain which affects gastrointestinal tract and causes several types of side-effects. Opioid induced constipation is the most common side-effect occur due to excessive usage of opioids.

Therapy Area
Hyperinsulinemia Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) GastroenterologyOthers

Hyperinsulinemia is a medical condition which is characterized by increased amount of insulin in blood. The primary cause of the disease is insulin resistance, which can also result in the development of type 2 diabetes. Insulinoma and nesidioblastosis are some other causes of hyperinsulinemia.

Therapy Area
Hepatorenal Syndrome Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) GastroenterologyOthers

Hepatorenal syndrome (HRS) is a reversible functional renal impairment, that occurs in patients with advanced liver cirrhosis or those with fulminant hepatic failure. It is characterized by a marked reduction in glomerular filtration rate and renal plasma flow, in the absence of other causes of renal failure. 

Therapy Area
Hepatitis E Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) GastroenterologyOthers

Hepatitis E is a liver disease caused by infection due to a virus known as hepatitis E virus (HEV). This disease can cause swelling in liver. Some of the common symptoms are mild fever, feeling of tiredness, feeling sick to stomach, and belly pain. 

Therapy Area
Gastroenteritis Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) GastroenterologyOthers

Gastroenteritis, also known as infectious diarrhoea, is an inflammatory disease caused by bacteria, viruses, or parasites through contaminated food and water. 

Therapy Area
Functional Dyspepsia Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) GastroenterologyOthers

Functional dyspepsia, also known as non-ulcer dyspepsia, is a gastrointestinal disorder that causes peristalsis and sensations in the upper digestive tract. Inflammation of the stomach or duodenum, excessive acid secretion, psychological factors, lifestyle and diet influences, food allergies, Helicobacter pylori infection, and side effects of medications are some causes of functional dyspepsia.

Therapy Area
Fecal Incontinence Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) GastroenterologyOthers

Fecal incontinence, also known as accidental bowel leakage, refers to the inability of a person to control bowel movement including stools and mucus. Urge incontinence is a common form of fecal incontinence that occur due to pelvic muscle injury or nerve damage. 

Therapy Area
Familial Adenomatous Polyposis (FAP) Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) GastroenterologyOthers

Familial adenomatous polyposis (FAP) is a genetic disorder, characterized by the development of adenomatous colon polyps in the intestinal tract, resulting in colon cancer. The disease is diagnosed when more than 100 adenomatous colon polyps are developed in a person.

Therapy Area
Exocrine Pancreatic Insufficiency (EPI) Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) GastroenterologyOthers

Exocrine pancreatic insufficiency (EPI) is the inability of pancreas to produce enough enzymes for the proper breakdown and absorption of nutrients. The common causes of EPI are damage to pancreas, inflammation of pancreas, pancreatic surgery, and inherited disorders like Crohn’s disease and celiac disease. 

Therapy Area
Diarrhoea Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) GastroenterologyOthers

Diarrhoea involves loose, frequent, and watery bowel movements, caused by gastrointestinal infections, medicines, and irritable bowel syndrome. Rotaviruses are the most common viral causative agents for this

Therapy Area
Crigler-Najjar Syndrome Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) GastroenterologyOthers

Crigler-Najjar syndrome is a severe condition, characterized by the high concentration of bilirubin (a toxic substance) in blood. Bilirubin is produced by liver due to the breakdown of red blood cells.

Therapy Area
Biliary Cirrhosis Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) GastroenterologyOthers

Biliary cirrhosis is an immune mediated chronic liver disease, in which small bile ducts are inflamed or injured, due to the building-up of bile level. If left untreated, biliary cirrhosis can lead to liver failure. In this disease, the immune system becomes overactive and attacks healthy bile ducts. 

Therapy Area
Abdominal Pain Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) GastroenterologyOthers

Abdominal pain is a sensation of distress or discomfort in the abdominal region. Some common related condition that can cause abdominal pain are chronic pelvic pain, constipation, gastritis, irritable bowel syndrome, diverticulitis, and menstrual pain. 

Therapy Area
Vitiligo Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) DermatologyOthers

Vitiligo is a type of autoimmune disorder which is characterized by white patches on skin. This is mainly due to destruction of melanocytes (cells responsible for pigmentation in the skin). People with certain autoimmune diseases are more prone to developing vitiligo. Some of the most common symptoms of the disease are occurrence of white patches on the hands, feet, arms, and lips.

Therapy Area
Venous Leg Ulcers (VLUs) Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) DermatologyOthers

Venous leg ulcers (VLUs) are defined as open lesions between the knee and ankle joint. It is the most common cause of leg ulcers, accounting for 60-80% of the total reported cases. The prevalence of VLUs is between 0.18% and 1%, which increases with age and can increased to 4% in patients aged 65 or above.

Therapy Area
Prurigo Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) DermatologyOthers

Prurigo is a group of skin diseases characterised by intensely pruritic, and difficult to treat. There are two conditions associated with prurigo which includes nodular prurigo and papular prurigo. Nodular prurigo is characterized by symmetrical lesions usually on the distal limbs; while, papular prurigo represents smaller lesions which affect cape area.

Therapy Area
Keratitis Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) DermatologyOthers

Keratitis is an inflammatory eye disorder which affects cornea. It is mainly caused by virus, bacteria, amoebic, and parasitic pathogens. Red eye, pain, excessive tearing, impaired eyesight, and photophobia are some of the symptoms associated with the disease. Keratitis is categorised into two types: acute keratitis and chronic keratitis.

Therapy Area
Keloids Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) DermatologyOthers

A keloid is characterized by abnormal proliferation of scar tissue which occurs at the site of cutaneous injuries. Acne scars, burns, scratches, ear piercing, chickenpox scars, surgical incision sites and vaccination sites are some of the major causes of keloids.

Therapy Area
Hidradenitis Suppurativa Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) DermatologyOthers

Hidradenitis suppurativa is a dermatological disorder which develops pimples, folliculitis, boils and deep-acne like cysts and blackheads. The pimples grow deeply in the skin and becomes painful in severe cases. Smoking and obesity are the most common risk factors of hidradenitis suppurativa. It is more prevalent in women compared to men. Hidradenitis suppurativa generally occurs in areas like underarms, groin, buttocks, upper thighs and breasts.

Therapy Area
Dermatomyositis Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) DermatologyOthers

Dermatomyositis is a rare inflammatory disease which can occur in any age. However, it is most common in children age group of 5 to 15 years, and people of late 40's and early 60's. Some of the most common symptoms observed in patients with dermatomyositis are erythema, inflammatory myopathy, myalgia, progressive muscle weakness, eyelid abnormality, and periorbital edema.

Therapy Area
Dermatomycoses Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) DermatologyOthers

Dermatomycoses is a group of disease which is caused by dermatophytes, a fungus, which generally invade into keratinized tissues such as nails, skin and hairs. The causative agents for dermatomycoses include organisms of three genera, Microsporum, Trichophyton, and Deuteromycetes. Dermatomycoses is a contagious disease that can be acquired from infected animals.

Therapy Area
Aging Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) DermatologyOthers

Aging is a process of becoming older, that brings physical, social and psychological changes to the body. In addition, aging is one of the major risk factors for the occurrence of many diseases. The cause of aging is still unknown; however, some proposed theories such as damage accumulation and programmed aging, are heading the hypothetical process of aging.

Therapy Area
Actinic Keratosis Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) DermatologyOthers

Actinic keratosis is a type of dermatological disorder characterized by thick and scaly patch of skin, that can lead to cancer. This disease generally occurs at the areas that are exposed to the sun and is common in people with fair skin. 

Therapy Area
Ventricular Arrhythmia Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) CardiovascularOthers

Ventricular arrhythmia is a cardiovascular disease that is characterized by slow beats (bradycardia) and fast beats (tachycardia). Ventricular arrhythmia generally occurs in the lower chamber of the heart.

Therapy Area
Telangiectasis Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) CardiovascularOthers

Telangiectasias are dilated blood vessels located near the surface of skin or mucous membranes. These often appear as fine pink or red lines, which temporarily whiten under pressure. Although this disease can be developed in healthy individuals, telangiectasias is known to be a prime feature of systemic and limited scleroderma and dermatomyositis.

Therapy Area
Left Ventricular Dysfunction Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) CardiovascularOthers

Left ventricular dysfunction is a condition which is characterized by dilation and vasoconstriction of left ventricle, which eventually lead to heart failure. Some common symptoms observed in this disease are insomnia, fatigue, and anxious or depressed mood. 

Therapy Area
Ischemic Cardiomyopathy Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) CardiovascularOthers

Ischemic cardiomyopathy is a type of dilated cardiomyopathy, in which the capability of heart to pump blood is reduced. This causes lack of blood supply to heart muscles which result in the occurrence of coronary artery disease. 

Therapy Area
Hypotension Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) CardiovascularOthers

Hypotension refers to a low blood pressure condition, which can result in dizziness, fainting or shock. There are several types of hypotension including orthostatic, neutrally mediated, and severe hypotension that are linked to shock. 

Therapy Area
Hypertrophic Cardiomyopathy Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) CardiovascularOthers

Hypertrophic cardiomyopathy, also known as an unexplained left ventricular hypertrophy, can lead to the sudden cardiac death. Some of the symptoms observed in patients suffering from this disease are chest pain, shortness of breath, orthostasis, palpitation, syncope, and presyncope. This disease can be diagnosed by imaging techniques, such as echocardiography and magnetic resonance imaging.

Therapy Area
Essential Hypertension Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) CardiovascularOthers

Essential hypertension, also known as idiopathic hypertension, is a kind of high blood pressure for which a secondary cause is not known. It is also known as primary hypertension and can eventually lead to atherosclerosis, stroke, heart attack, heart failure, eye and kidney damage. 

Therapy Area
Dilated Cardiomyopathy Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) CardiovascularOthers

Dilated cardiomyopathy is a type of cardiovascular disease, that is characterized by left systolic dysfunction and ventricular enlargement. This condition is found to be associated with cardiac arrhythmias, congestive heart failure, and thromboembolic disease.

Therapy Area
Behcet Disease (Behçet disease) Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Therapeutic Area(s) CardiovascularOthers

Behcet Disease (Behçet disease) is an inflammatory disorder that affects blood vessels of various body parts including mouth, genitals, skin, and eyes. Some of the symptoms of this disease are mouth sores, skin sores, genital sores, uveitis, joint swelling, abdominal pain, headache, and fever.